Another New Zealand Public Healthcare Provider Signs Up to Cxbladder
14th August 2018

Cancer diagnostics company Pacific Edge (NZX: PEB) has received notification from Counties Manukau District Health Board (CMDHB) regarding adoption of the suite of Cxbladder cancer diagnostic tests for use across the clinical pathway. Read More

Pacific Edge Signs First Commercial Agreement in Singapore
01st February 2018

Cancer diagnostics company, Pacific Edge Limited (NZX:PEB) has reached a commercial agreement with Raffles Diagnostica Pte Ltd to offer its suite of Cxbladder tests in Singapore. Read More